Prevention of urinary tract device encrustation
AssigneeDevicare SL
InventorJordi CUÑE
Life of this patent
Estimating the term…
Abstract
The present disclosure provides compositions and methods to prevent or reduce the encrustation of medical devices inserted in the urinary tract, such as a urinary stents (e.g., JJ stents). The reduction or prevention can result in an improvement in the quality of life of the patient by, e.g., reducing pain and/or tissue damage caused during the removal of an encrusted device.
Claims20
A method to facilitate the removal of a urinary tract device in a subject in need thereof comprising administering to the subject:
- (i) at least one dose of an oral composition that decreases urine pH, if the subject's urine pH is above a pH threshold or pH range;
- (ii) at least one dose of an oral composition that increases urine pH, if the subject's urine pH is below a pH threshold or pH range;
- (iii) at least one dose of an oral composition that maintains urine pH, if the subject's urine pH is within a pH range;
- or,
- (iv) a combination thereof;
- wherein the administration of the compositions to the subject reduces encrustation on the surface of the urinary tract device, and the reduced encrustation facilitates the removal of the urinary tract device.
A method to prevent encrustation on a urinary tract device in a subject in need thereof comprising administering to the subject:
- (i) at least one dose of an oral composition that decreases urine pH, if the subject's urine pH is above a pH threshold or pH range;
- (ii) at least one dose of an oral composition that increases urine pH, if the subject's urine pH is below a pH threshold or pH range;
- (iii) at least one dose of an oral composition that maintains urine pH, if the subject's urine pH is within a pH range;
- or,
- (iv) a combination thereof;
- wherein the administration of the compositions to the subject reduces encrustation on the surface of the urinary tract device.
Dependencies are inferred from the claim text.